GMO U.S. Quality ETF (NYSEARCA:QLTY – Get Free Report) saw a large increase in short interest during the month of September. As of September 30th, there was short interest totaling 142,204 shares, an increase of 100.6% from the September 15th total of 70,884 shares. Approximately 0.1% of the shares of the company are short sold. Based on an average daily volume of 386,721 shares, the short-interest ratio is presently 0.4 days.
GMO U.S. Quality ETF Price Performance
GMO U.S. Quality ETF stock traded down $0.17 during mid-day trading on Wednesday, reaching $43.92. 76,183 shares of the company traded hands, compared to its average volume of 533,096. The firm’s fifty day moving average is $43.06 and its two-hundred day moving average is $41.28. The company has a market capitalization of $5.39 billion, a price-to-earnings ratio of 60.94 and a beta of 0.97. GMO U.S. Quality ETF has a fifty-two week low of $35.15 and a fifty-two week high of $44.24.
GMO U.S. Quality ETF Cuts Dividend
The business also recently disclosed a quarterly dividend, which was paid on Thursday, October 1st. Stockholders of record on Wednesday, September 30th were paid a dividend of $0.0613 per share. The ex-dividend date was Wednesday, September 30th. This is a decrease from GMO U.S. Quality ETF’s previous quarterly dividend of $0.0754. This represents a $0.25 annualized dividend and a dividend yield of 0.6%. GMO U.S. Quality ETF’s payout ratio is presently 38.89%.
Hedge Funds Weigh In On GMO U.S. Quality ETF
GMO U.S. Quality ETF Company Profile
The GMO U.S. Quality ETF (QLTY) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed fund that focuses on equities of high-quality US companies. The funds investments may include companies of any market capitalization. QLTY was launched on Nov 13, 2023 and is issued by GMO.
Further Reading
- Five stocks we like better than GMO U.S. Quality ETF
- Birkenstock’s Strong Growth Creates a Buying Opportunity
- High Voltage Returns: Navitas Rewires AI Data Centers
- Quantum BioPharma’s Phase 2 Shows Where Biotech Value Actually Gets Built
- Albertsons Is Betting on a Turnaround—But Will It Pay Off?
Receive News & Ratings for GMO U.S. Quality ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GMO U.S. Quality ETF and related companies with MarketBeat.com's FREE daily email newsletter.
